Molecular mimicry and primary biliary cirrhosis: Premises not promises
2001; Lippincott Williams & Wilkins; Volume: 33; Issue: 4 Linguagem: Inglês
10.1053/jhep.2001.23902
ISSN1527-3350
AutoresJudy Van de Water, Hiromi Ishibashi, Ross L. Coppel, Eric M. Gershwin,
Tópico(s)Paraoxonase enzyme and polymorphisms
ResumoHepatologyVolume 33, Issue 4 p. 771-775 Concise ReviewFree Access Molecular mimicry and primary biliary cirrhosis: Premises not promises Judy Van de Water, Judy Van de Water Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CASearch for more papers by this authorHiromi Ishibashi, Hiromi Ishibashi The First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, JapanSearch for more papers by this authorRoss L. Coppel, Ross L. Coppel Department of Microbiology, Monash University, Clayton, Victoria, AustraliaSearch for more papers by this authorM. Eric Gershwin M.D., Corresponding Author M. Eric Gershwin M.D. [email protected] Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CADivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, TB 192, One Shields Avenue, Davis, CA 95616. fax: 530-752-4669.===Search for more papers by this author Judy Van de Water, Judy Van de Water Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CASearch for more papers by this authorHiromi Ishibashi, Hiromi Ishibashi The First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, JapanSearch for more papers by this authorRoss L. Coppel, Ross L. Coppel Department of Microbiology, Monash University, Clayton, Victoria, AustraliaSearch for more papers by this authorM. Eric Gershwin M.D., Corresponding Author M. Eric Gershwin M.D. [email protected] Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CADivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, TB 192, One Shields Avenue, Davis, CA 95616. fax: 530-752-4669.===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jhep.2001.23902Citations: 71AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94: 2125–2129. MEDLINE 2 Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol 1995; 38: 170–175. MEDLINE 3 Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705. MEDLINE 4 Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, Melief CJ, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 1999; 190: 169–176. MEDLINE 5 Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210–225. MEDLINE 6 Van de Water J, Turchany J, Leung PS, Lake J, Munoz S, Surh CD, Coppel R, et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993; 91: 2653–2664. MEDLINE 7 Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31: 1212–1216. MEDLINE 8 Barnaba V, Sinigaglia F. Molecular mimicry and T cell-mediated autoimmune disease. J Exp Med 1997; 185: 1529–1531. MEDLINE 9 Zucker-Franklin D. Non-HIV retroviral associations with rheumatic disease. Curr Rheumatol Rep 2000; 2: 156–162. MEDLINE 10 Ramos-Casals M, Cervera R, Garcia-Carrasco M, Vidal J, Trejo O, Jimenez S, Costa J, et al. Cytopenia and past human parvovirus B19 infection in patients with primary Sjogren's syndrome. Semin Arthritis Rheum 2000; 29: 373–378. MEDLINE 11 Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H, Wilson C, Collado A, et al. Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin Rheumatol 1996; 15(Suppl 1): 57–61. MEDLINE 12 Eichbaum QG, Beatty DW, Parker MI. Identification of cardiac autoantigens in human heart cDNA libraries using acute rheumatic fever sera. J Autoimmun 1994; 7: 243–261. MEDLINE 13 Karopoulos C, Rowley MJ, Handley CJ, Strugnell RA. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. J Autoimmun 1995; 8: 235–248. MEDLINE 14 Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A 1990; 87: 3987–3991. MEDLINE 15 Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181: 1835–1845. MEDLINE 16 Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 1995; 35: 473–485. MEDLINE 17 Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995; 1271: 111–121. MEDLINE 18 Vilagut L, Vila J, Viñnas O, Parés A, Ginés A, Jiménez de Anta MT, Rodés J. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 1994; 21: 673–677. MEDLINE 19 Vilagut L, Parés A, Viñnas O, Vila J, Jiménez de Anta MT, Rodés J. Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997; 27: 667–672. MEDLINE 20 O'Donohue J, McFarlane B, Bomford A, Yates M, Williams R. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol 1994; 21: 887–889. MEDLINE 21 Bogdanos DP, Grasso A, Okamoto M, Montalto P, Butler P, Williams R, Baum H, et al. Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis [Abstract]. Hepatology 2000; 32: 300A. 22 Owen P, Kaback HR, Grame-Cook KA. Identification of antigen 19/27 as dihydrolipoyl dehydrogenase and its probable involvement in ubiquinone-mediated NADH-dependent transport phenomena in membrane vesicles of Escherichia coli. FEMS Microbiol Lett 1980; 7: 345–348. 23 Li de la Sierra I, Pernot L, Prangé T, Saludjian P, Schiltz M, Fourme R, Padróon G. Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J Mol Biol 1997; 269: 129–141. MEDLINE 24 Danson MJ, Conroy K, McQuattie A, Stevenson KJ. Dihydrolipoamide dehydrogenase from Trypanosoma brucei. Characterization and cellular location. Biochem J 1987; 243: 661–665. MEDLINE 25 Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102: 1831–1840. MEDLINE 26 Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, Ansari A, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999; 31: 664–671. MEDLINE 27 Reynoso-Paz S, Leung PS, Van De Water J, Tanaka A, Munoz S, Bass N, Lindor K, et al. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 2000; 31: 24–29. MEDLINE 28 Migliaccio C, Nishio A, Van de Water J, Ansari AA, Leung PS, Nakanuma Y, Coppel RL, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 1998; 161: 5157–5163. MEDLINE 29a Migliaccio C, Van de Water J, Ansari AA, Kaplan MM, Coppel RL, Lam KS, Thompson RK, et al. Heterogenous response of antimitochondrial antibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology 2001; 33: 792–801. 29 Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci 1995; 56: 1299–1310. MEDLINE 30 Shanklin DR, Smalley DL. The immunopathology of siliconosis. History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone. Immunol Res 1998; 18: 125–173. MEDLINE 31 Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210–225. MEDLINE 32 D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000; 112-113: 421–432. 33 al-Balaghi S, Moller E, Moller G, Abedi-Valugerdi M. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB × NZW)F1 hybrids. Eur J Immunol 1996; 26: 1519–1526. MEDLINE 34 Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res 1999; 20: 67–78. MEDLINE 35 Rose NR, Burek CL. Autoantibodies to thyroglobulin in health and disease. Appl Biochem Biotechnol 2000; 83: 245–251; discussion 251-244, 297-313. 36 Babu BR, Frey C, Griffith OW. L-arginine binding to nitric-oxide synthase. The role of H-bonds to the nonreactive guanidinium nitrogens. J Biol Chem 1999; 274: 25218–25226. MEDLINE 37 Rao T, Richardson B. Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect 1999; 107(Suppl 5): 737–742. MEDLINE 38 Powell JJ, Van de Water J, Gershwin ME. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 1999; 107(Suppl 5): 667–672. 39 Pumford NR, Halmes NC. Protein targets of xenobiotic reactive intermediates. Ann Rev Pharmacol Toxicol 1997; 37: 91–117. 40 Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol 2000; 32: 181–197. MEDLINE 41 Eliasson E, Gardner I, Hume-Smith H, de Waziers I, Beaune P, Kenna JG. Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis. Chem Biol Interact 1998; 116: 123–141. MEDLINE 42 Christen U, Quinn J, Yeaman S, Kenna J, Clarke J, Gandolfi A, Gut J. Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid. Eur J Biochem 1994; 223: 1035–1047. MEDLINE 43 Frey N, Christen U, Jeno P, Yeaman SJ, Shimomura Y, Kenna JG, Gandolfi AJ, et al. The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis. Chem Res Toxicol 1995; 8: 736–746. MEDLINE 44 Bustamante J, Lodge J, Marcocci L, Tritschler H, Packer L, Rihn B. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998; 24: 1023–1039. MEDLINE 45 Humphries K, Szweda L. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 1998; 37: 15835–15841. MEDLINE 46 Yoshida S, Gershwin ME. Autoimmunity and selected environmental factors of disease induction. Semin Arthitis Rheum 1993; 22: 399–419. 47 Simat TJ, Kleeberg KK, Muller B, Sierts A. Synthesis, formation, and occurrence of contaminants in biotechnologically manufactured L-tryptophan. Adv Exp Med Biol 1999; 467: 469–480. MEDLINE 48 Hess EV. Are there environmental forms of systemic autoimmune diseases? Environ Health Perspect 1999; 107(Suppl 5): 709–711. MEDLINE 49 Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am J Ind Med 1995; 28: 603–608. MEDLINE 50 Pumford NR, Halmes NC, Hinson JA. Covalent binding of xenobiotics to specific proteins in the liver. Drug Metab Rev 1997; 29: 39–57. MEDLINE Citing Literature Volume33, Issue4April 2001Pages 771-775 ReferencesRelatedInformation
Referência(s)